nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—UGT1A4—hematopoietic system—stomach cancer	0.0125	0.121	CbGeAlD
Paricalcitol—CYP24A1—hematopoietic system—stomach cancer	0.0125	0.121	CbGeAlD
Paricalcitol—CYP24A1—digestive system—stomach cancer	0.00871	0.0839	CbGeAlD
Paricalcitol—UGT1A4—digestive system—stomach cancer	0.00871	0.0839	CbGeAlD
Paricalcitol—CYP24A1—endocrine gland—stomach cancer	0.0072	0.0694	CbGeAlD
Paricalcitol—UGT1A4—endocrine gland—stomach cancer	0.0072	0.0694	CbGeAlD
Paricalcitol—VDR—hematopoietic system—stomach cancer	0.0069	0.0665	CbGeAlD
Paricalcitol—UGT1A4—liver—stomach cancer	0.00649	0.0625	CbGeAlD
Paricalcitol—VDR—epithelium—stomach cancer	0.00631	0.0608	CbGeAlD
Paricalcitol—VDR—lymphoid tissue—stomach cancer	0.00486	0.0468	CbGeAlD
Paricalcitol—VDR—digestive system—stomach cancer	0.0048	0.0462	CbGeAlD
Paricalcitol—VDR—bone marrow—stomach cancer	0.00442	0.0426	CbGeAlD
Paricalcitol—VDR—endocrine gland—stomach cancer	0.00396	0.0382	CbGeAlD
Paricalcitol—VDR—lymph node—stomach cancer	0.00274	0.0264	CbGeAlD
Paricalcitol—CYP3A4—hematopoietic system—stomach cancer	0.00231	0.0222	CbGeAlD
Paricalcitol—CYP3A4—digestive system—stomach cancer	0.0016	0.0155	CbGeAlD
Paricalcitol—CYP3A4—endocrine gland—stomach cancer	0.00133	0.0128	CbGeAlD
Paricalcitol—CYP3A4—liver—stomach cancer	0.00119	0.0115	CbGeAlD
Paricalcitol—UGT1A4—Biological oxidations—GSTT1—stomach cancer	0.000934	0.00263	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP2A6—stomach cancer	0.000923	0.0026	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000912	0.00257	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—stomach cancer	0.000898	0.00253	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.000896	0.00253	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000885	0.0025	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF559—stomach cancer	0.000882	0.00249	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	0.000868	0.00245	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000844	0.00238	CbGpPWpGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000838	0.00236	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HBEGF—stomach cancer	0.000832	0.00235	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTP1—stomach cancer	0.00081	0.00228	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000806	0.00227	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTP1—stomach cancer	0.000798	0.00225	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—stomach cancer	0.000776	0.00219	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PRPF19—stomach cancer	0.00075	0.00212	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTM1—stomach cancer	0.000744	0.0021	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTP1—stomach cancer	0.000738	0.00208	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—stomach cancer	0.000735	0.00207	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTM1—stomach cancer	0.000734	0.00207	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—RXRB—stomach cancer	0.000729	0.00206	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HMOX1—stomach cancer	0.000728	0.00205	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ACAD8—stomach cancer	0.000696	0.00196	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	0.000683	0.00193	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.00068	0.00192	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTM1—stomach cancer	0.000678	0.00191	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF160—stomach cancer	0.000669	0.00189	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.00066	0.00186	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000654	0.00184	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	0.00065	0.00183	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTP1—stomach cancer	0.000647	0.00183	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.00064	0.0018	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTP1—stomach cancer	0.000638	0.0018	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GMPR2—stomach cancer	0.00062	0.00175	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EEF1A2—stomach cancer	0.000611	0.00172	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CAV1—stomach cancer	0.000599	0.00169	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000599	0.00169	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTM1—stomach cancer	0.000595	0.00168	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000592	0.00167	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—RORA—stomach cancer	0.00059	0.00166	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000587	0.00166	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTM1—stomach cancer	0.000587	0.00165	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MET—stomach cancer	0.00058	0.00164	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	0.000579	0.00163	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000575	0.00162	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SUCLG1—stomach cancer	0.000567	0.0016	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—IDH3B—stomach cancer	0.000567	0.0016	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	0.000561	0.00158	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ACAD8—stomach cancer	0.000556	0.00157	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—APC—stomach cancer	0.000546	0.00154	CbGpPWpGaD
Paricalcitol—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000533	0.0015	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NDUFS1—stomach cancer	0.000527	0.00149	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NDUFV1—stomach cancer	0.000527	0.00149	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—RARB—stomach cancer	0.000527	0.00149	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000516	0.00145	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HNRNPL—stomach cancer	0.000507	0.00143	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GMPR2—stomach cancer	0.000496	0.0014	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MMP2—stomach cancer	0.000484	0.00136	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EEF1A1—stomach cancer	0.000483	0.00136	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SERPINE1—stomach cancer	0.000475	0.00134	CbGpPWpGaD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000473	0.00133	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—BLVRB—stomach cancer	0.00047	0.00133	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PGLS—stomach cancer	0.00047	0.00133	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	0.000465	0.00131	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—IDH3B—stomach cancer	0.000454	0.00128	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SUCLG1—stomach cancer	0.000454	0.00128	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPAP2A—stomach cancer	0.000448	0.00127	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000431	0.00122	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NDUFV1—stomach cancer	0.000422	0.00119	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NDUFS1—stomach cancer	0.000422	0.00119	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CPSF1—stomach cancer	0.000417	0.00118	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EXOSC5—stomach cancer	0.000417	0.00118	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—POLR3K—stomach cancer	0.000405	0.00114	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CA1—stomach cancer	0.0004	0.00113	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CKB—stomach cancer	0.0004	0.00113	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NDUFA2—stomach cancer	0.0004	0.00113	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FBP1—stomach cancer	0.0004	0.00113	CbGpPWpGaD
Paricalcitol—Dermatitis—Irinotecan—stomach cancer	0.000387	0.000714	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000387	0.000714	CcSEcCtD
Paricalcitol—Chills—Methotrexate—stomach cancer	0.000386	0.000713	CcSEcCtD
Paricalcitol—Headache—Irinotecan—stomach cancer	0.000385	0.00071	CcSEcCtD
Paricalcitol—Hypotension—Capecitabine—stomach cancer	0.000384	0.000709	CcSEcCtD
Paricalcitol—Insomnia—Docetaxel—stomach cancer	0.000384	0.000709	CcSEcCtD
Paricalcitol—Paraesthesia—Docetaxel—stomach cancer	0.000381	0.000704	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—stomach cancer	0.000381	0.000703	CcSEcCtD
Paricalcitol—Dyspnoea—Docetaxel—stomach cancer	0.000378	0.000699	CcSEcCtD
Paricalcitol—Somnolence—Docetaxel—stomach cancer	0.000377	0.000697	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—stomach cancer	0.000377	0.000697	CcSEcCtD
Paricalcitol—Eye disorder—Epirubicin—stomach cancer	0.000377	0.000695	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—BLVRB—stomach cancer	0.000376	0.00106	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PGLS—stomach cancer	0.000376	0.00106	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLIN2—stomach cancer	0.000376	0.00106	CbGpPWpGaD
Paricalcitol—Malnutrition—Methotrexate—stomach cancer	0.000375	0.000692	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000374	0.000691	CcSEcCtD
Paricalcitol—Cardiac disorder—Epirubicin—stomach cancer	0.000374	0.000691	CcSEcCtD
Paricalcitol—Vomiting—Fluorouracil—stomach cancer	0.000374	0.00069	CcSEcCtD
Paricalcitol—Dyspepsia—Docetaxel—stomach cancer	0.000374	0.00069	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—JUN—stomach cancer	0.000374	0.00105	CbGpPWpGaD
Paricalcitol—Insomnia—Capecitabine—stomach cancer	0.000372	0.000686	CcSEcCtD
Paricalcitol—Hypoaesthesia—Doxorubicin—stomach cancer	0.000371	0.000685	CcSEcCtD
Paricalcitol—Rash—Fluorouracil—stomach cancer	0.000371	0.000685	CcSEcCtD
Paricalcitol—Dermatitis—Fluorouracil—stomach cancer	0.000371	0.000684	CcSEcCtD
Paricalcitol—Pharyngitis—Doxorubicin—stomach cancer	0.00037	0.000683	CcSEcCtD
Paricalcitol—Paraesthesia—Capecitabine—stomach cancer	0.000369	0.000681	CcSEcCtD
Paricalcitol—Decreased appetite—Docetaxel—stomach cancer	0.000369	0.000681	CcSEcCtD
Paricalcitol—Headache—Fluorouracil—stomach cancer	0.000368	0.00068	CcSEcCtD
Paricalcitol—Urinary tract disorder—Doxorubicin—stomach cancer	0.000368	0.00068	CcSEcCtD
Paricalcitol—Oedema peripheral—Doxorubicin—stomach cancer	0.000367	0.000678	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—stomach cancer	0.000367	0.000678	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000367	0.000677	CcSEcCtD
Paricalcitol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000366	0.000677	CcSEcCtD
Paricalcitol—Dyspnoea—Capecitabine—stomach cancer	0.000366	0.000676	CcSEcCtD
Paricalcitol—Fatigue—Docetaxel—stomach cancer	0.000366	0.000676	CcSEcCtD
Paricalcitol—Angiopathy—Epirubicin—stomach cancer	0.000366	0.000675	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CA2—stomach cancer	0.000366	0.00103	CbGpPWpGaD
Paricalcitol—Urethral disorder—Doxorubicin—stomach cancer	0.000366	0.000675	CcSEcCtD
Paricalcitol—Nausea—Irinotecan—stomach cancer	0.000365	0.000673	CcSEcCtD
Paricalcitol—Immune system disorder—Epirubicin—stomach cancer	0.000364	0.000672	CcSEcCtD
Paricalcitol—Mediastinal disorder—Epirubicin—stomach cancer	0.000363	0.000671	CcSEcCtD
Paricalcitol—Pain—Docetaxel—stomach cancer	0.000363	0.00067	CcSEcCtD
Paricalcitol—Constipation—Docetaxel—stomach cancer	0.000363	0.00067	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—stomach cancer	0.000363	0.000669	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—CDKN1A—stomach cancer	0.000362	0.00102	CbGpPWpGaD
Paricalcitol—Dyspepsia—Capecitabine—stomach cancer	0.000362	0.000668	CcSEcCtD
Paricalcitol—Chills—Epirubicin—stomach cancer	0.000362	0.000668	CcSEcCtD
Paricalcitol—Arrhythmia—Epirubicin—stomach cancer	0.00036	0.000665	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PPAP2A—stomach cancer	0.000359	0.00101	CbGpPWpGaD
Paricalcitol—Decreased appetite—Capecitabine—stomach cancer	0.000357	0.00066	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PGAM1—stomach cancer	0.000356	0.001	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NT5E—stomach cancer	0.000356	0.001	CbGpPWpGaD
Paricalcitol—Alopecia—Epirubicin—stomach cancer	0.000356	0.000657	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000355	0.000655	CcSEcCtD
Paricalcitol—Fatigue—Capecitabine—stomach cancer	0.000354	0.000654	CcSEcCtD
Paricalcitol—Mental disorder—Epirubicin—stomach cancer	0.000353	0.000652	CcSEcCtD
Paricalcitol—Pain—Capecitabine—stomach cancer	0.000351	0.000649	CcSEcCtD
Paricalcitol—Constipation—Capecitabine—stomach cancer	0.000351	0.000649	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RXRB—stomach cancer	0.000351	0.000991	CbGpPWpGaD
Paricalcitol—Malnutrition—Epirubicin—stomach cancer	0.000351	0.000648	CcSEcCtD
Paricalcitol—Feeling abnormal—Docetaxel—stomach cancer	0.00035	0.000646	CcSEcCtD
Paricalcitol—Nausea—Fluorouracil—stomach cancer	0.000349	0.000645	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—stomach cancer	0.000349	0.000643	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000348	0.000981	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Methotrexate—stomach cancer	0.000348	0.000642	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000347	0.000641	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—stomach cancer	0.000347	0.00064	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—stomach cancer	0.000346	0.000639	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RPL13—stomach cancer	0.000344	0.000971	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPL18—stomach cancer	0.000344	0.000971	CbGpPWpGaD
Paricalcitol—Tension—Epirubicin—stomach cancer	0.000344	0.000636	CcSEcCtD
Paricalcitol—Dysgeusia—Epirubicin—stomach cancer	0.000344	0.000634	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000343	0.000968	CbGpPWpGaD
Paricalcitol—Nervousness—Epirubicin—stomach cancer	0.000341	0.000629	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PLCE1—stomach cancer	0.00034	0.000959	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALDH7A1—stomach cancer	0.00034	0.000959	CbGpPWpGaD
Paricalcitol—Back pain—Epirubicin—stomach cancer	0.000339	0.000627	CcSEcCtD
Paricalcitol—Feeling abnormal—Capecitabine—stomach cancer	0.000339	0.000625	CcSEcCtD
Paricalcitol—Angiopathy—Doxorubicin—stomach cancer	0.000338	0.000625	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—stomach cancer	0.000338	0.000624	CcSEcCtD
Paricalcitol—Muscle spasms—Epirubicin—stomach cancer	0.000337	0.000623	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—stomach cancer	0.000337	0.000622	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—stomach cancer	0.000337	0.000622	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000336	0.00062	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000336	0.00062	CcSEcCtD
Paricalcitol—Body temperature increased—Docetaxel—stomach cancer	0.000336	0.00062	CcSEcCtD
Paricalcitol—Abdominal pain—Docetaxel—stomach cancer	0.000336	0.00062	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—stomach cancer	0.000336	0.00062	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—stomach cancer	0.000335	0.000618	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—stomach cancer	0.000333	0.000615	CcSEcCtD
Paricalcitol—Alopecia—Doxorubicin—stomach cancer	0.00033	0.000608	CcSEcCtD
Paricalcitol—Cough—Methotrexate—stomach cancer	0.000327	0.000604	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—stomach cancer	0.000327	0.000603	CcSEcCtD
Paricalcitol—Urticaria—Capecitabine—stomach cancer	0.000327	0.000603	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—UMPS—stomach cancer	0.000326	0.000919	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Epirubicin—stomach cancer	0.000326	0.000601	CcSEcCtD
Paricalcitol—Abdominal pain—Capecitabine—stomach cancer	0.000325	0.0006	CcSEcCtD
Paricalcitol—Body temperature increased—Capecitabine—stomach cancer	0.000325	0.0006	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—stomach cancer	0.000325	0.000599	CcSEcCtD
Paricalcitol—Anaemia—Epirubicin—stomach cancer	0.000324	0.000599	CcSEcCtD
Paricalcitol—Agitation—Epirubicin—stomach cancer	0.000322	0.000595	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RPS21—stomach cancer	0.000321	0.000906	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPS15—stomach cancer	0.000321	0.000906	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FBP1—stomach cancer	0.00032	0.000901	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CA1—stomach cancer	0.00032	0.000901	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CKB—stomach cancer	0.00032	0.000901	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NDUFA2—stomach cancer	0.00032	0.000901	CbGpPWpGaD
Paricalcitol—Myalgia—Methotrexate—stomach cancer	0.000319	0.000589	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—stomach cancer	0.000319	0.000589	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—stomach cancer	0.000319	0.000589	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—stomach cancer	0.000319	0.000588	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—stomach cancer	0.000318	0.000587	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000317	0.000585	CcSEcCtD
Paricalcitol—Malaise—Epirubicin—stomach cancer	0.000316	0.000584	CcSEcCtD
Paricalcitol—VDR—Gene Expression—SNRPB—stomach cancer	0.000316	0.000892	CbGpPWpGaD
Paricalcitol—Discomfort—Methotrexate—stomach cancer	0.000315	0.000582	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—stomach cancer	0.000315	0.000582	CcSEcCtD
Paricalcitol—Vertigo—Epirubicin—stomach cancer	0.000315	0.000582	CcSEcCtD
Paricalcitol—Syncope—Epirubicin—stomach cancer	0.000315	0.000581	CcSEcCtD
Paricalcitol—Leukopenia—Epirubicin—stomach cancer	0.000314	0.00058	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—stomach cancer	0.000314	0.00058	CcSEcCtD
Paricalcitol—Hypersensitivity—Docetaxel—stomach cancer	0.000313	0.000577	CcSEcCtD
Paricalcitol—Muscle spasms—Doxorubicin—stomach cancer	0.000312	0.000576	CcSEcCtD
Paricalcitol—Palpitations—Epirubicin—stomach cancer	0.00031	0.000572	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—stomach cancer	0.000309	0.00057	CcSEcCtD
Paricalcitol—Loss of consciousness—Epirubicin—stomach cancer	0.000308	0.000569	CcSEcCtD
Paricalcitol—Cough—Epirubicin—stomach cancer	0.000306	0.000565	CcSEcCtD
Paricalcitol—Asthenia—Docetaxel—stomach cancer	0.000305	0.000562	CcSEcCtD
Paricalcitol—Infection—Methotrexate—stomach cancer	0.000304	0.000561	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PDHA1—stomach cancer	0.000303	0.000855	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ECHS1—stomach cancer	0.000303	0.000855	CbGpPWpGaD
Paricalcitol—Hypertension—Epirubicin—stomach cancer	0.000303	0.000559	CcSEcCtD
Paricalcitol—Hypersensitivity—Capecitabine—stomach cancer	0.000303	0.000559	CcSEcCtD
Paricalcitol—Ill-defined disorder—Doxorubicin—stomach cancer	0.000301	0.000556	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PLIN2—stomach cancer	0.0003	0.000848	CbGpPWpGaD
Paricalcitol—Pruritus—Docetaxel—stomach cancer	0.0003	0.000554	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—stomach cancer	0.0003	0.000554	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—stomach cancer	0.0003	0.000554	CcSEcCtD
Paricalcitol—Chest pain—Epirubicin—stomach cancer	0.000299	0.000551	CcSEcCtD
Paricalcitol—Myalgia—Epirubicin—stomach cancer	0.000299	0.000551	CcSEcCtD
Paricalcitol—Arthralgia—Epirubicin—stomach cancer	0.000299	0.000551	CcSEcCtD
Paricalcitol—Agitation—Doxorubicin—stomach cancer	0.000298	0.000551	CcSEcCtD
Paricalcitol—Anxiety—Epirubicin—stomach cancer	0.000298	0.00055	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—stomach cancer	0.000297	0.000549	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000297	0.000548	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—stomach cancer	0.000296	0.000546	CcSEcCtD
Paricalcitol—Discomfort—Epirubicin—stomach cancer	0.000295	0.000545	CcSEcCtD
Paricalcitol—Asthenia—Capecitabine—stomach cancer	0.000295	0.000544	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—EGFR—stomach cancer	0.000294	0.000829	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SMAD4—stomach cancer	0.000293	0.000827	CbGpPWpGaD
Paricalcitol—Malaise—Doxorubicin—stomach cancer	0.000293	0.00054	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CA2—stomach cancer	0.000292	0.000824	CbGpPWpGaD
Paricalcitol—Dry mouth—Epirubicin—stomach cancer	0.000292	0.000539	CcSEcCtD
Paricalcitol—Vertigo—Doxorubicin—stomach cancer	0.000292	0.000538	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—stomach cancer	0.000292	0.000538	CcSEcCtD
Paricalcitol—Syncope—Doxorubicin—stomach cancer	0.000291	0.000537	CcSEcCtD
Paricalcitol—Pruritus—Capecitabine—stomach cancer	0.000291	0.000537	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—stomach cancer	0.000291	0.000536	CcSEcCtD
Paricalcitol—Diarrhoea—Docetaxel—stomach cancer	0.00029	0.000536	CcSEcCtD
Paricalcitol—Confusional state—Epirubicin—stomach cancer	0.000289	0.000533	CcSEcCtD
Paricalcitol—Palpitations—Doxorubicin—stomach cancer	0.000287	0.00053	CcSEcCtD
Paricalcitol—Oedema—Epirubicin—stomach cancer	0.000286	0.000529	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—stomach cancer	0.000286	0.000528	CcSEcCtD
Paricalcitol—Loss of consciousness—Doxorubicin—stomach cancer	0.000285	0.000527	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—NT5E—stomach cancer	0.000285	0.000803	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PGAM1—stomach cancer	0.000285	0.000803	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FADS1—stomach cancer	0.000285	0.000803	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TYMP—stomach cancer	0.000285	0.000803	CbGpPWpGaD
Paricalcitol—Infection—Epirubicin—stomach cancer	0.000284	0.000525	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RORA—stomach cancer	0.000284	0.000801	CbGpPWpGaD
Paricalcitol—Cough—Doxorubicin—stomach cancer	0.000283	0.000523	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000282	0.000796	CbGpPWpGaD
Paricalcitol—Shock—Epirubicin—stomach cancer	0.000282	0.00052	CcSEcCtD
Paricalcitol—Diarrhoea—Capecitabine—stomach cancer	0.000281	0.000519	CcSEcCtD
Paricalcitol—Nervous system disorder—Epirubicin—stomach cancer	0.000281	0.000518	CcSEcCtD
Paricalcitol—Dizziness—Docetaxel—stomach cancer	0.000281	0.000518	CcSEcCtD
Paricalcitol—Hypertension—Doxorubicin—stomach cancer	0.00028	0.000517	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000279	0.000515	CcSEcCtD
Paricalcitol—Skin disorder—Epirubicin—stomach cancer	0.000278	0.000513	CcSEcCtD
Paricalcitol—Hyperhidrosis—Epirubicin—stomach cancer	0.000277	0.000511	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—stomach cancer	0.000277	0.000511	CcSEcCtD
Paricalcitol—Myalgia—Doxorubicin—stomach cancer	0.000276	0.00051	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—stomach cancer	0.000276	0.00051	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—stomach cancer	0.000276	0.00051	CcSEcCtD
Paricalcitol—Anxiety—Doxorubicin—stomach cancer	0.000275	0.000508	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—stomach cancer	0.000275	0.000507	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000274	0.000507	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—stomach cancer	0.000273	0.000504	CcSEcCtD
Paricalcitol—Anorexia—Epirubicin—stomach cancer	0.000273	0.000504	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—stomach cancer	0.000273	0.000504	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—stomach cancer	0.000272	0.000502	CcSEcCtD
Paricalcitol—Dizziness—Capecitabine—stomach cancer	0.000272	0.000502	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PLCE1—stomach cancer	0.000272	0.000766	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALDH7A1—stomach cancer	0.000272	0.000766	CbGpPWpGaD
Paricalcitol—Dry mouth—Doxorubicin—stomach cancer	0.00027	0.000499	CcSEcCtD
Paricalcitol—Vomiting—Docetaxel—stomach cancer	0.00027	0.000498	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—stomach cancer	0.000269	0.000497	CcSEcCtD
Paricalcitol—Rash—Docetaxel—stomach cancer	0.000268	0.000494	CcSEcCtD
Paricalcitol—Hypotension—Epirubicin—stomach cancer	0.000268	0.000494	CcSEcCtD
Paricalcitol—Dermatitis—Docetaxel—stomach cancer	0.000267	0.000494	CcSEcCtD
Paricalcitol—Confusional state—Doxorubicin—stomach cancer	0.000267	0.000493	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—SREBF2—stomach cancer	0.000267	0.000752	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DNMT3B—stomach cancer	0.000266	0.000751	CbGpPWpGaD
Paricalcitol—Decreased appetite—Methotrexate—stomach cancer	0.000266	0.000491	CcSEcCtD
Paricalcitol—Headache—Docetaxel—stomach cancer	0.000266	0.000491	CcSEcCtD
Paricalcitol—Oedema—Doxorubicin—stomach cancer	0.000265	0.000489	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000264	0.000488	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—stomach cancer	0.000264	0.000487	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—RORA—stomach cancer	0.000264	0.000743	CbGpPWpGaD
Paricalcitol—Infection—Doxorubicin—stomach cancer	0.000263	0.000486	CcSEcCtD
Paricalcitol—Pain—Methotrexate—stomach cancer	0.000262	0.000483	CcSEcCtD
Paricalcitol—Vomiting—Capecitabine—stomach cancer	0.000261	0.000482	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RPL15—stomach cancer	0.000261	0.000736	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000261	0.000482	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—stomach cancer	0.000261	0.000481	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—UMPS—stomach cancer	0.000261	0.000735	CbGpPWpGaD
Paricalcitol—Nervous system disorder—Doxorubicin—stomach cancer	0.00026	0.00048	CcSEcCtD
Paricalcitol—Rash—Capecitabine—stomach cancer	0.000259	0.000478	CcSEcCtD
Paricalcitol—Insomnia—Epirubicin—stomach cancer	0.000259	0.000478	CcSEcCtD
Paricalcitol—Dermatitis—Capecitabine—stomach cancer	0.000259	0.000478	CcSEcCtD
Paricalcitol—Headache—Capecitabine—stomach cancer	0.000257	0.000475	CcSEcCtD
Paricalcitol—Skin disorder—Doxorubicin—stomach cancer	0.000257	0.000475	CcSEcCtD
Paricalcitol—Paraesthesia—Epirubicin—stomach cancer	0.000257	0.000475	CcSEcCtD
Paricalcitol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000256	0.000473	CcSEcCtD
Paricalcitol—Dyspnoea—Epirubicin—stomach cancer	0.000255	0.000471	CcSEcCtD
Paricalcitol—Somnolence—Epirubicin—stomach cancer	0.000255	0.00047	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RARB—stomach cancer	0.000254	0.000716	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000253	0.000714	CbGpPWpGaD
Paricalcitol—Anorexia—Doxorubicin—stomach cancer	0.000253	0.000466	CcSEcCtD
Paricalcitol—Nausea—Docetaxel—stomach cancer	0.000252	0.000466	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—stomach cancer	0.000252	0.000465	CcSEcCtD
Paricalcitol—Dyspepsia—Epirubicin—stomach cancer	0.000252	0.000465	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—stomach cancer	0.00025	0.000462	CcSEcCtD
Paricalcitol—Decreased appetite—Epirubicin—stomach cancer	0.000249	0.00046	CcSEcCtD
Paricalcitol—Hypotension—Doxorubicin—stomach cancer	0.000248	0.000457	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000247	0.000456	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALDOB—stomach cancer	0.000247	0.000697	CbGpPWpGaD
Paricalcitol—Fatigue—Epirubicin—stomach cancer	0.000247	0.000456	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—stomach cancer	0.000247	0.000696	CbGpPWpGaD
Paricalcitol—Constipation—Epirubicin—stomach cancer	0.000245	0.000452	CcSEcCtD
Paricalcitol—Pain—Epirubicin—stomach cancer	0.000245	0.000452	CcSEcCtD
Paricalcitol—Nausea—Capecitabine—stomach cancer	0.000244	0.000451	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RPS26—stomach cancer	0.000243	0.000687	CbGpPWpGaD
Paricalcitol—Urticaria—Methotrexate—stomach cancer	0.000243	0.000449	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PDHA1—stomach cancer	0.000242	0.000683	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ECHS1—stomach cancer	0.000242	0.000683	CbGpPWpGaD
Paricalcitol—Body temperature increased—Methotrexate—stomach cancer	0.000242	0.000447	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—stomach cancer	0.000242	0.000447	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000241	0.000446	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—stomach cancer	0.00024	0.000442	CcSEcCtD
Paricalcitol—Paraesthesia—Doxorubicin—stomach cancer	0.000238	0.000439	CcSEcCtD
Paricalcitol—Dyspnoea—Doxorubicin—stomach cancer	0.000236	0.000436	CcSEcCtD
Paricalcitol—Feeling abnormal—Epirubicin—stomach cancer	0.000236	0.000436	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—stomach cancer	0.000236	0.000435	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Epirubicin—stomach cancer	0.000234	0.000432	CcSEcCtD
Paricalcitol—Dyspepsia—Doxorubicin—stomach cancer	0.000233	0.000431	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000233	0.000657	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000232	0.000655	CbGpPWpGaD
Paricalcitol—Decreased appetite—Doxorubicin—stomach cancer	0.00023	0.000425	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALOX5—stomach cancer	0.00023	0.000648	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000229	0.000422	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—stomach cancer	0.000228	0.000422	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—TYMP—stomach cancer	0.000228	0.000642	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FADS1—stomach cancer	0.000228	0.000642	CbGpPWpGaD
Paricalcitol—Urticaria—Epirubicin—stomach cancer	0.000227	0.00042	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—stomach cancer	0.000227	0.000418	CcSEcCtD
Paricalcitol—Constipation—Doxorubicin—stomach cancer	0.000227	0.000418	CcSEcCtD
Paricalcitol—Abdominal pain—Epirubicin—stomach cancer	0.000226	0.000418	CcSEcCtD
Paricalcitol—Body temperature increased—Epirubicin—stomach cancer	0.000226	0.000418	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—DPYD—stomach cancer	0.000226	0.000637	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Methotrexate—stomach cancer	0.000225	0.000416	CcSEcCtD
Paricalcitol—Asthenia—Methotrexate—stomach cancer	0.00022	0.000405	CcSEcCtD
Paricalcitol—Feeling abnormal—Doxorubicin—stomach cancer	0.000218	0.000403	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000217	0.0004	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—stomach cancer	0.000216	0.0004	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SREBF2—stomach cancer	0.000213	0.000601	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HSPB1—stomach cancer	0.000213	0.0006	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Epirubicin—stomach cancer	0.000211	0.000389	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—RORA—stomach cancer	0.000211	0.000594	CbGpPWpGaD
Paricalcitol—Urticaria—Doxorubicin—stomach cancer	0.00021	0.000389	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—stomach cancer	0.000209	0.000387	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—stomach cancer	0.000209	0.000387	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—stomach cancer	0.000209	0.000386	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RPS19—stomach cancer	0.000207	0.000584	CbGpPWpGaD
Paricalcitol—Asthenia—Epirubicin—stomach cancer	0.000205	0.000379	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000205	0.000577	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—stomach cancer	0.000204	0.000576	CbGpPWpGaD
Paricalcitol—Pruritus—Epirubicin—stomach cancer	0.000203	0.000374	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—stomach cancer	0.000202	0.000374	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTT1—stomach cancer	0.0002	0.000563	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DNMT1—stomach cancer	0.000198	0.000558	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2A6—stomach cancer	0.000197	0.000557	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALDOB—stomach cancer	0.000197	0.000557	CbGpPWpGaD
Paricalcitol—Diarrhoea—Epirubicin—stomach cancer	0.000196	0.000362	CcSEcCtD
Paricalcitol—Hypersensitivity—Doxorubicin—stomach cancer	0.000195	0.00036	CcSEcCtD
Paricalcitol—VDR—Gene Expression—HSPA8—stomach cancer	0.000195	0.00055	CbGpPWpGaD
Paricalcitol—Vomiting—Methotrexate—stomach cancer	0.000195	0.000359	CcSEcCtD
Paricalcitol—Rash—Methotrexate—stomach cancer	0.000193	0.000356	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—stomach cancer	0.000193	0.000356	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—AKR1C3—stomach cancer	0.000192	0.000542	CbGpPWpGaD
Paricalcitol—Headache—Methotrexate—stomach cancer	0.000192	0.000354	CcSEcCtD
Paricalcitol—Asthenia—Doxorubicin—stomach cancer	0.00019	0.000351	CcSEcCtD
Paricalcitol—Dizziness—Epirubicin—stomach cancer	0.000189	0.00035	CcSEcCtD
Paricalcitol—Pruritus—Doxorubicin—stomach cancer	0.000187	0.000346	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ENO1—stomach cancer	0.000187	0.000528	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000184	0.000519	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—stomach cancer	0.000184	0.000519	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5—stomach cancer	0.000184	0.000518	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPS6—stomach cancer	0.000183	0.000516	CbGpPWpGaD
Paricalcitol—Vomiting—Epirubicin—stomach cancer	0.000182	0.000336	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—stomach cancer	0.000182	0.000336	CcSEcCtD
Paricalcitol—Diarrhoea—Doxorubicin—stomach cancer	0.000181	0.000335	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—DPYD—stomach cancer	0.000181	0.000509	CbGpPWpGaD
Paricalcitol—Rash—Epirubicin—stomach cancer	0.000181	0.000333	CcSEcCtD
Paricalcitol—Dermatitis—Epirubicin—stomach cancer	0.00018	0.000333	CcSEcCtD
Paricalcitol—Headache—Epirubicin—stomach cancer	0.000179	0.000331	CcSEcCtD
Paricalcitol—Dizziness—Doxorubicin—stomach cancer	0.000175	0.000323	CcSEcCtD
Paricalcitol—Nausea—Epirubicin—stomach cancer	0.00017	0.000314	CcSEcCtD
Paricalcitol—Vomiting—Doxorubicin—stomach cancer	0.000168	0.000311	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—stomach cancer	0.000167	0.000308	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—stomach cancer	0.000167	0.000308	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CD44—stomach cancer	0.000166	0.000468	CbGpPWpGaD
Paricalcitol—Headache—Doxorubicin—stomach cancer	0.000166	0.000306	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000161	0.000454	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTT1—stomach cancer	0.00016	0.00045	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2A6—stomach cancer	0.000158	0.000445	CbGpPWpGaD
Paricalcitol—Nausea—Doxorubicin—stomach cancer	0.000157	0.000291	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—AKR1C3—stomach cancer	0.000154	0.000433	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPP2R1A—stomach cancer	0.000152	0.000429	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000152	0.000428	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.00015	0.000423	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ENO1—stomach cancer	0.00015	0.000422	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000144	0.000405	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SMAD4—stomach cancer	0.000141	0.000398	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPP2R1A—stomach cancer	0.000141	0.000398	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTP1—stomach cancer	0.000138	0.000391	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMOX1—stomach cancer	0.000137	0.000385	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CD44—stomach cancer	0.000133	0.000374	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ERCC2—stomach cancer	0.000129	0.000364	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TYMS—stomach cancer	0.000129	0.000363	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—stomach cancer	0.000127	0.000359	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ERCC2—stomach cancer	0.00012	0.000337	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—MYC—stomach cancer	0.000116	0.000328	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPP2R1A—stomach cancer	0.000113	0.000318	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—stomach cancer	0.000112	0.000317	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTP1—stomach cancer	0.000111	0.000312	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMOX1—stomach cancer	0.000109	0.000308	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—stomach cancer	0.000105	0.000296	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAV1—stomach cancer	0.000104	0.000293	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	0.000104	0.000292	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA1—stomach cancer	0.000103	0.000292	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TYMS—stomach cancer	0.000103	0.00029	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—stomach cancer	0.000102	0.000287	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.91e-05	0.000279	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—stomach cancer	9.83e-05	0.000277	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—stomach cancer	9.65e-05	0.000272	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ERCC2—stomach cancer	9.56e-05	0.00027	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	9.52e-05	0.000269	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—stomach cancer	9.12e-05	0.000257	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACAD8—stomach cancer	9.03e-05	0.000255	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—stomach cancer	8.99e-05	0.000254	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—stomach cancer	8.85e-05	0.00025	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAV1—stomach cancer	8.29e-05	0.000234	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA1—stomach cancer	8.27e-05	0.000233	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—stomach cancer	8.2e-05	0.000231	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GMPR2—stomach cancer	8.05e-05	0.000227	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—stomach cancer	7.84e-05	0.000221	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SUCLG1—stomach cancer	7.36e-05	0.000208	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—IDH3B—stomach cancer	7.36e-05	0.000208	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—stomach cancer	7.29e-05	0.000206	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—stomach cancer	7.17e-05	0.000202	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NDUFS1—stomach cancer	6.85e-05	0.000193	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NDUFV1—stomach cancer	6.85e-05	0.000193	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—stomach cancer	6.55e-05	0.000185	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—stomach cancer	6.27e-05	0.000177	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PGLS—stomach cancer	6.1e-05	0.000172	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BLVRB—stomach cancer	6.1e-05	0.000172	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPAP2A—stomach cancer	5.82e-05	0.000164	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MAPK3—stomach cancer	5.76e-05	0.000162	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—stomach cancer	5.73e-05	0.000162	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MYC—stomach cancer	5.6e-05	0.000158	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CKB—stomach cancer	5.19e-05	0.000146	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NDUFA2—stomach cancer	5.19e-05	0.000146	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FBP1—stomach cancer	5.19e-05	0.000146	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA1—stomach cancer	5.19e-05	0.000146	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLIN2—stomach cancer	4.88e-05	0.000138	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA2—stomach cancer	4.74e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PGAM1—stomach cancer	4.62e-05	0.00013	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NT5E—stomach cancer	4.62e-05	0.00013	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CA—stomach cancer	4.41e-05	0.000124	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLCE1—stomach cancer	4.41e-05	0.000124	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH7A1—stomach cancer	4.41e-05	0.000124	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UMPS—stomach cancer	4.23e-05	0.000119	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PDHA1—stomach cancer	3.93e-05	0.000111	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ECHS1—stomach cancer	3.93e-05	0.000111	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FADS1—stomach cancer	3.7e-05	0.000104	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TYMP—stomach cancer	3.7e-05	0.000104	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CA—stomach cancer	3.53e-05	9.95e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SREBF2—stomach cancer	3.46e-05	9.76e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—RORA—stomach cancer	3.42e-05	9.65e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDOB—stomach cancer	3.2e-05	9.04e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5—stomach cancer	2.98e-05	8.4e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DPYD—stomach cancer	2.93e-05	8.27e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—stomach cancer	2.59e-05	7.31e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.56e-05	7.23e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.49e-05	7.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO1—stomach cancer	2.43e-05	6.85e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CD44—stomach cancer	2.15e-05	6.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.83e-05	5.17e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—stomach cancer	1.8e-05	5.07e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—stomach cancer	1.77e-05	5e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TYMS—stomach cancer	1.67e-05	4.71e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—stomach cancer	1.65e-05	4.66e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ERCC2—stomach cancer	1.55e-05	4.38e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—stomach cancer	1.46e-05	4.12e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAV1—stomach cancer	1.35e-05	3.8e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA1—stomach cancer	1.34e-05	3.79e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—stomach cancer	1.18e-05	3.34e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—stomach cancer	1.06e-05	3e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—stomach cancer	1.02e-05	2.87e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—stomach cancer	9.31e-06	2.63e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CA—stomach cancer	5.73e-06	1.62e-05	CbGpPWpGaD
